Oxcarbazepine

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 239 -
2005 233  6
2006 248  15
2007 246  2
2008 225  21
2009 286  61
Year Rank Change
2010 207  79
2011 206  1
2012 197  9
2013 212  15
2014 160  52
2015 176  16

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2015)
Gabapentin 43,320,666
Lamotrigine 12,096,328
Divalproex Sodium 6,112,173
Phenytoin 4,171,794
Oxcarbazepine (this drug) 3,735,666
Primidone 1,506,283

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Oxtellar XR
  • Trileptal
Generic Drug Synonyms and Salts
  • Oxcarbazepine

FDA Approval Information

Established Pharmacologic Class (EPC): Anti-epileptic Agent
Initial FDA approval date: 1/14/2000
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top